Cancer Antigen Discovery Is Enabled by RNA Sequencing of Highly Purified Malignant and Nonmalignant Cells. (2020)

First Author: Scurr MJ
Attributed to:  Utilising proteomics to develop anti-HCMV immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-19-3087

PubMed Identifier: 32122920

Publication URI: http://europepmc.org/abstract/MED/32122920

Type: Journal Article/Review

Volume: 26

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 13

ISSN: 1078-0432